Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Day One Biopharmaceuticals (DAWN) EPS (Weighted Average and Diluted): 2023-2025

Historic EPS (Weighted Average and Diluted) for Day One Biopharmaceuticals (DAWN) over the last 3 years, with Sep 2025 value amounting to -$0.19.

  • Day One Biopharmaceuticals' EPS (Weighted Average and Diluted) fell 150.00% to -$0.19 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.52, marking a year-over-year decrease of 47.57%. This contributed to the annual value of -$1.02 for FY2024, which is 56.96% up from last year.
  • As of Q3 2025, Day One Biopharmaceuticals' EPS (Weighted Average and Diluted) stood at -$0.19, which was up 34.48% from -$0.29 recorded in Q2 2025.
  • In the past 5 years, Day One Biopharmaceuticals' EPS (Weighted Average and Diluted) ranged from a high of $0.38 in Q3 2024 and a low of -$0.72 during Q1 2024.
  • Over the past 3 years, Day One Biopharmaceuticals' median EPS (Weighted Average and Diluted) value was -$0.45 (recorded in 2023), while the average stood at -$0.37.
  • As far as peak fluctuations go, Day One Biopharmaceuticals' EPS (Weighted Average and Diluted) skyrocketed by 170.37% in 2024, and later slumped by 480.00% in 2025.
  • Over the past 3 years, Day One Biopharmaceuticals' EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.64 in 2023, then dropped by 7.81% to -$0.69 in 2024, then tumbled by 150.00% to -$0.19 in 2025.
  • Its last three reported values are -$0.19 in Q3 2025, -$0.29 for Q2 2025, and -$0.35 during Q1 2025.